ODDB.org: Open Drug Database

Swissmedic Registration	69695	Date of registration	03.02.2025
Company name	Pfizer AG	Revision date
		Valid until	02.02.2030
Indication		Date of market entry
Index Therapeuticus (BSV)		Revocation Date
Index Therapeuticus (Swissmedic)	07.15.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Litfulo 50 mg	Hartkapseln	Capsules (Ritlecitinibum 50 mg)	L04AF08	CI

2025	©ywesee GmbH